[ORGANIZATION]
Takeda Pharmaceuticals
Featured in 2 tracked stories · first seen
Situations
FDA, Japan, and China approve Orzeyful for narcolepsy
4 clusters · 9 sources · last updated
Latest: Orzeyful receives global approvals for narcolepsy type 1 treatment
The U.S. Food and Drug Administration has approved Takeda’s Orzeyful (oveporexton), the first oral orexin-2 receptor agonist for adults with narcolepsy type 1. Unlike previous treatments that manage symptoms, Orzeyful ta
FDA approval of Lisraya for dermatomyositis
2 clusters · 15 sources · last updated
Latest: FDA approves new treatments for dermatomyositis and polycythemia vera
The U.S. Food and Drug Administration (FDA) has approved Lisraya (brepocitinib), developed by Priovant Therapeutics, as the first targeted oral therapy specifically for adults with dermatomyositis. This rare autoimmune d